Annual revenue:
$160.18M-$34.44M(-17.70%)Summary
- As of today (September 14, 2025), AKBA annual revenue is $160.18 million, with the most recent change of -$34.44 million (-17.70%) on December 31, 2024.
- During the last 3 years, AKBA annual revenue has fallen by -$51.47 million (-24.32%).
- AKBA annual revenue is now -52.19% below its all-time high of $335.00 million, reached on December 31, 2019.
Performance
AKBA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$62.47M+$5.14M(+8.96%)Summary
- As of today (September 14, 2025), AKBA quarterly revenue is $62.47 million, with the most recent change of +$5.14 million (+8.96%) on June 1, 2025.
- Over the past year, AKBA quarterly revenue has increased by +$18.82 million (+43.13%).
- AKBA quarterly revenue is now -50.56% below its all-time high of $126.36 million, reached on June 30, 2022.
Performance
AKBA Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$203.73M+$18.82M(+10.18%)Summary
- As of today (September 14, 2025), AKBA TTM revenue is $203.73 million, with the most recent change of +$18.82 million (+10.18%) on June 1, 2025.
- Over the past year, AKBA TTM revenue has increased by +$29.24 million (+16.75%).
- AKBA TTM revenue is now -41.93% below its all-time high of $350.81 million, reached on March 31, 2020.
Performance
AKBA TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AKBA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.7% | +43.1% | +16.8% |
| 3 y3 years | -24.3% | -50.6% | -30.8% |
| 5 y5 years | -52.2% | -30.7% | -40.1% |
AKBA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -45.2% | at low | -50.6% | +91.6% | -30.8% | +27.2% |
| 5 y | 5-year | -52.2% | at low | -50.6% | +91.6% | -40.1% | +27.2% |
| alltime | all time | -52.2% | >+9999.0% | -50.6% | >+9999.0% | -41.9% | >+9999.0% |
AKBA Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $62.47M(+9.0%) | $203.73M(+10.2%) |
| Mar 2025 | - | $57.34M(+23.3%) | $184.91M(+15.4%) |
| Dec 2024 | $160.18M(-17.7%) | $46.50M(+24.2%) | $160.18M(-5.7%) |
| Sep 2024 | - | $37.43M(-14.3%) | $169.88M(-2.6%) |
| Jun 2024 | - | $43.65M(+33.9%) | $174.50M(-6.8%) |
| Mar 2024 | - | $32.61M(-42.0%) | $187.22M(-3.8%) |
| Dec 2023 | $194.62M(-33.5%) | $56.20M(+33.7%) | $194.62M(+0.6%) |
| Sep 2023 | - | $42.05M(-25.4%) | $193.49M(-3.3%) |
| Jun 2023 | - | $56.38M(+40.9%) | $200.16M(-25.9%) |
| Mar 2023 | - | $40.01M(-27.3%) | $270.15M(-7.4%) |
| Dec 2022 | $292.48M(+38.2%) | $55.06M(+13.0%) | $291.84M(-0.9%) |
| Sep 2022 | - | $48.71M(-61.4%) | $294.45M(-0.0%) |
| Jun 2022 | - | $126.36M(+104.8%) | $294.50M(+33.2%) |
| Mar 2022 | - | $61.70M(+7.0%) | $221.04M(+4.4%) |
| Dec 2021 | $211.65M(-28.3%) | $57.68M(+18.3%) | $211.65M(+0.5%) |
| Sep 2021 | - | $48.76M(-7.9%) | $210.67M(-5.1%) |
| Jun 2021 | - | $52.91M(+1.2%) | $221.90M(-14.4%) |
| Mar 2021 | - | $52.30M(-7.8%) | $259.13M(-12.2%) |
| Dec 2020 | $295.31M(-11.8%) | $56.70M(-5.5%) | $295.31M(-4.2%) |
| Sep 2020 | - | $59.99M(-33.5%) | $308.16M(-9.4%) |
| Jun 2020 | - | $90.14M(+1.9%) | $340.15M(-3.0%) |
| Mar 2020 | - | $88.48M(+27.2%) | $350.81M(+4.7%) |
| Dec 2019 | $335.00M(+61.3%) | $69.56M(-24.4%) | $335.00M(+3.0%) |
| Sep 2019 | - | $91.98M(-8.8%) | $325.30M(+13.5%) |
| Jun 2019 | - | $100.80M(+38.7%) | $286.49M(+22.2%) |
| Mar 2019 | - | $72.67M(+21.4%) | $234.48M(+12.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $207.74M(+14.6%) | $59.85M(+12.6%) | $207.74M(-12.9%) |
| Sep 2018 | - | $53.17M(+9.0%) | $238.45M(+5.2%) |
| Jun 2018 | - | $48.79M(+6.2%) | $226.56M(+9.8%) |
| Mar 2018 | - | $45.93M(-49.3%) | $206.29M(+13.8%) |
| Dec 2017 | $181.23M(>+9900.0%) | $90.56M(+119.4%) | $181.23M(+96.6%) |
| Sep 2017 | - | $41.28M(+44.8%) | $92.20M(+81.1%) |
| Jun 2017 | - | $28.52M(+36.7%) | $50.92M(+127.3%) |
| Mar 2017 | - | $20.86M(+1259.3%) | $22.40M(+1359.3%) |
| Dec 2016 | $1.53M(>+9900.0%) | $1.53M(>+9900.0%) | $1.53M(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | - | - |
| Dec 2012 | - | $0.00 | $0.00 |
| Dec 2011 | $0.00 | - | - |
FAQ
- What is Akebia Therapeutics, Inc. annual revenue?
- What is the all time high annual revenue for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual revenue year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly revenue year-on-year change?
- What is Akebia Therapeutics, Inc. TTM revenue?
- What is the all time high TTM revenue for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. TTM revenue year-on-year change?
What is Akebia Therapeutics, Inc. annual revenue?
The current annual revenue of AKBA is $160.18M
What is the all time high annual revenue for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual revenue is $335.00M
What is Akebia Therapeutics, Inc. annual revenue year-on-year change?
Over the past year, AKBA annual revenue has changed by -$34.44M (-17.70%)
What is Akebia Therapeutics, Inc. quarterly revenue?
The current quarterly revenue of AKBA is $62.47M
What is the all time high quarterly revenue for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly revenue is $126.36M
What is Akebia Therapeutics, Inc. quarterly revenue year-on-year change?
Over the past year, AKBA quarterly revenue has changed by +$18.82M (+43.13%)
What is Akebia Therapeutics, Inc. TTM revenue?
The current TTM revenue of AKBA is $203.73M
What is the all time high TTM revenue for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high TTM revenue is $350.81M
What is Akebia Therapeutics, Inc. TTM revenue year-on-year change?
Over the past year, AKBA TTM revenue has changed by +$29.24M (+16.75%)